Life Science Compliance Update



Maintaining Independence & Objectivity – OIG Releases New IRO Guidance

Written by , Posted in Compliance operations

Kaitlin Fallon Wildoner, Esq., Senior Staff Writer, Life Science Compliance Update

The Health and Human Services Office of Inspector General has released new guidance on an important topic, Independent Review Organizations within Corporate Integrity Agreements. This article goes through the recent guidance and explains the requirements of objectivity and independence. The conclusion also provides several practical takeaways from the new guidelines.


Gravityscan Badge
Menu Title